D
David A. Anderson
Researcher at Dalhousie University
Publications - 10
Citations - 847
David A. Anderson is an academic researcher from Dalhousie University. The author has contributed to research in topics: Risk factor & Warfarin. The author has an hindex of 9, co-authored 10 publications receiving 781 citations.
Papers
More filters
Journal ArticleDOI
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
Marc A. Rodger,Susan R. Kahn,Philip S. Wells,David A. Anderson,Isabelle Chagnon,Grégoire Le Gal,Susan Solymoss,Mark Crowther,Arnaud Perrier,Richard H. White,Linda M. Vickars,Tim Ramsay,M. T. Betancourt,Michael J. Kovacs +13 more
TL;DR: Women with 0 or 1 risk factor may safely discontinue oral anticoagulant therapy after 6 months of therapy following a first unprovoked venous thromboembolism, and this criterion does not apply to men.
Journal ArticleDOI
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
Grégoire Le Gal,Michael J. Kovacs,Marc Carrier,Kimberley Do,Susan R. Kahn,Philip S. Wells,David A. Anderson,Isabelle Chagnon,Susan Solymoss,Mark Crowther,Marc Philip Righini,Karine Lacut,Richard H. White,Linda M. Vickars,Marc A. Rodger +14 more
TL;DR: The risk of recurrent VTE is low in women after a first otherwise unprovoked oestrogen-associated VTE, however, this risk is not significantly lower than in women whose VTE was not related to oestrogens use.
Journal ArticleDOI
Validation of a diagnostic approach to exclude recurrent venous thromboembolism.
G. Le Gal,Michael J. Kovacs,Marc Carrier,Marc Carrier,K. Do,Susan R. Kahn,Susan R. Kahn,P. S. Wells,P. S. Wells,David A. Anderson,Isabelle Chagnon,Susan Solymoss,Mark Crowther,Marc Philip Righini,Arnaud Perrier,Richard H. White,Linda M. Vickars,Marc A. Rodger,Marc A. Rodger +18 more
TL;DR: A diagnostic strategy comparing diagnostic test results obtained at the time of the suspected recurrent event with those obtained at baseline can safely and effectively rule out recurrent VTE in a significant proportion of patients.
Journal ArticleDOI
Non-OO blood type influences the risk of recurrent venous thromboembolism
Esteban Gandara,Michael J. Kovacs,Susan R. Kahn,Philip S. Wells,David A. Anderson,Isabelle Chagnon,Grégoire Le Gal,Susan Solymoss,Mark Crowther,Marc Carrier,Nicole Langlois,Judy Kovacs,Julian Little Ma,Nancy Carson,Tim Ramsay,Marc A. Rodger +15 more
TL;DR: Non-OO blood type is associated with a statistically significant and clinically relevant increased risk of recurrent VTE following discontinuation of anticoagulant therapy for a first episode of unprovoked VTE.
Journal ArticleDOI
Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study
G. Le Gal,Marc Carrier,Marc Carrier,Michael J. Kovacs,M. T. Betancourt,Susan R. Kahn,Susan R. Kahn,P. S. Wells,P. S. Wells,David A. Anderson,Isabelle Chagnon,Susan Solymoss,Mark Crowther,Marc Philip Righini,Aurélien Delluc,Richard H. White,Linda M. Vickars,Marc A. Rodger,Marc A. Rodger +18 more
TL;DR: Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta‐analysis.